AVTR

Avantor, Inc.
$8.12
+0.25 (+3.18%)
Mkt Cap 5.54B
Volume 5,124,721
52W Range 7.265-15.93
Sector Healthcare
Beta 0.94
EPS (TTM) -0.80
P/E Ratio -14.65
Revenue (TTM) 6.55B
Rev Growth (5Y) +0.5%
EPS Growth (5Y) N/A
AlphaVal · Fair Value
$5.37
Overvalued · Strong
51.3% above fair value
AlphaQuality · Grade
D+
Platform & Compounding FCF
39.4 / 100 composite

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 6.55B 6.78B 6.97B 7.51B 7.39B 6.39B 6.04B 5.86B 1.25B 691.30M 636.90M
Net Income (530.20M) 711.50M 321.10M 686.50M 572.60M 116.60M 37.80M (86.90M) (112.70M) (42.40M) 21.60M
EPS -0.78 1.05 0.48 1.02 0.86 0.09 -0.84 -0.72 -0.84 -0.09 0.04
Free Cash Flow 495.00M 692.00M 723.60M 710.20M 842.50M 868.20M 302.40M 162.80M (192.70M) 43.00M N/A
FCF / Share 0.73 1.02 1.07 1.09 1.43 1.51 0.75 0.33 -0.39 0.09 N/A
Operating CF 623.80M 840.80M 870.00M 843.60M 953.60M 929.80M 354.00M 200.50M (167.50M) 72.90M N/A
Total Assets 11.79B 12.11B 12.97B 13.46B 13.90B 9.91B 9.77B 9.91B 10.45B 1.14B N/A
Total Debt 3.95B 4.06B 5.54B 6.29B 7.02B 4.89B 5.12B 6.92B 7.12B 1.30B N/A
Cash & Equiv 365.40M 261.90M 262.90M 372.90M 301.70M 286.60M 186.70M 184.70M 185.40M 62.90M N/A
Book Value 5.57B 5.96B 5.25B 4.86B 4.20B 2.67B 2.46B (3.05B) (2.62B) (374.90M) N/A
Return on Equity -0.10 0.12 0.06 0.14 0.14 0.04 0.02 N/A N/A N/A N/A
AVTR News
Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory
May 19, 2026 02:05 AM · prnewswire.com
Avantor Q1 Earnings & Revenues Beat Estimates, Margins Decline
Apr 30, 2026 09:40 AM · zacks.com
Avantor Q1 2026 Earnings Review: Stabilization Emerging, But Recovery Not Yet Visible
Apr 30, 2026 09:03 AM · seekingalpha.com
Avantor, Inc. (AVTR) Q1 2026 Earnings Call Transcript
Apr 29, 2026 09:12 AM · seekingalpha.com
Avantor, Inc. (AVTR) Q1 Earnings and Revenues Top Estimates
Apr 29, 2026 04:46 AM · zacks.com
Avantor® Reports First Quarter 2026 Results
Apr 29, 2026 02:05 AM · prnewswire.com
Avantor® Announces Ludovic Brellier as Executive Vice President, Bioscience & Medtech Products (BMP) & Chief Transformation Officer
Apr 23, 2026 01:05 PM · prnewswire.com
Avantor Expands Masterflex Portfolio to Streamline Bioprocessing
Apr 22, 2026 09:41 AM · zacks.com
Kuehn Law Encourages Investors of Avantor, Inc. to Contact Law Firm
Apr 22, 2026 05:32 AM · globenewswire.com
Avantor® Unifies Masterflex® Portfolio to Streamline Fluid Management from R&D to Bioprocess Manufacturing
Apr 21, 2026 04:05 AM · prnewswire.com